Cargando…
Postoperative high-sensitivity troponin T predicts 1-year mortality and days alive and out of hospital after orthotopic heart transplantation
BACKGROUND: Orthotopic heart transplantation (HTX) is the gold standard to treat end-stage heart failure. Numerous risk stratification tools have been developed in the past years. However, their clinical utility is limited by their poor discriminative ability. High sensitivity troponin T (hsTnT) is...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827673/ https://www.ncbi.nlm.nih.gov/pubmed/36624515 http://dx.doi.org/10.1186/s40001-022-00978-4 |
_version_ | 1784867097935872000 |
---|---|
author | M’Pembele, René Roth, Sebastian Nucaro, Anthony Stroda, Alexandra Tenge, Theresa Lurati Buse, Giovanna Bönner, Florian Scheiber, Daniel Ballázs, Christina Tudorache, Igor Aubin, Hug Lichtenberg, Artur Huhn, Ragnar Boeken, Udo |
author_facet | M’Pembele, René Roth, Sebastian Nucaro, Anthony Stroda, Alexandra Tenge, Theresa Lurati Buse, Giovanna Bönner, Florian Scheiber, Daniel Ballázs, Christina Tudorache, Igor Aubin, Hug Lichtenberg, Artur Huhn, Ragnar Boeken, Udo |
author_sort | M’Pembele, René |
collection | PubMed |
description | BACKGROUND: Orthotopic heart transplantation (HTX) is the gold standard to treat end-stage heart failure. Numerous risk stratification tools have been developed in the past years. However, their clinical utility is limited by their poor discriminative ability. High sensitivity troponin T (hsTnT) is the most specific biomarker to detect myocardial cell injury. However, its prognostic relevance after HTX is not fully elucidated. Thus, this study evaluated the predictive value of postoperative hsTnT for 1-year survival and days alive and out of hospital (DAOH) after HTX. METHODS: This retrospective cohort study included patients who underwent HTX at the University Hospital Duesseldorf, Germany between 2011 and 2021. The main exposure was hsTnT concentration at 48 h after HTX. The primary endpoints were mortality and DAOH within 1 year after surgery. Receiver operating characteristic (ROC) curve analysis, logistic regression model and linear regression with adjustment for risk index for mortality prediction after cardiac transplantation (IMPACT) were performed. RESULTS: Out of 231 patients screened, 212 were included into analysis (mean age 55 ± 11 years, 73% male). One-year mortality was 19.7% (40 patients) and median DAOH was 298 days (229–322). ROC analysis revealed strongest discrimination for mortality by hsTnT at 48 h after HTX [AUC = 0.79 95% CI 0.71–0.87]. According to Youden Index, the cutoff for hsTnT at 48 h and mortality was 1640 ng/l. After adjustment for IMPACT score multivariate logistic and linear regression showed independent associations between hsTnT and mortality/DAOH with odds ratio of 8.10 [95%CI 2.99–21.89] and unstandardized regression coefficient of −1.54 [95%CI −2.02 to −1.06], respectively. CONCLUSION: Postoperative hsTnT might be suitable as an early prognostic marker after HTX and is independently associated with 1-year mortality and poor DAOH. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40001-022-00978-4. |
format | Online Article Text |
id | pubmed-9827673 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-98276732023-01-10 Postoperative high-sensitivity troponin T predicts 1-year mortality and days alive and out of hospital after orthotopic heart transplantation M’Pembele, René Roth, Sebastian Nucaro, Anthony Stroda, Alexandra Tenge, Theresa Lurati Buse, Giovanna Bönner, Florian Scheiber, Daniel Ballázs, Christina Tudorache, Igor Aubin, Hug Lichtenberg, Artur Huhn, Ragnar Boeken, Udo Eur J Med Res Research BACKGROUND: Orthotopic heart transplantation (HTX) is the gold standard to treat end-stage heart failure. Numerous risk stratification tools have been developed in the past years. However, their clinical utility is limited by their poor discriminative ability. High sensitivity troponin T (hsTnT) is the most specific biomarker to detect myocardial cell injury. However, its prognostic relevance after HTX is not fully elucidated. Thus, this study evaluated the predictive value of postoperative hsTnT for 1-year survival and days alive and out of hospital (DAOH) after HTX. METHODS: This retrospective cohort study included patients who underwent HTX at the University Hospital Duesseldorf, Germany between 2011 and 2021. The main exposure was hsTnT concentration at 48 h after HTX. The primary endpoints were mortality and DAOH within 1 year after surgery. Receiver operating characteristic (ROC) curve analysis, logistic regression model and linear regression with adjustment for risk index for mortality prediction after cardiac transplantation (IMPACT) were performed. RESULTS: Out of 231 patients screened, 212 were included into analysis (mean age 55 ± 11 years, 73% male). One-year mortality was 19.7% (40 patients) and median DAOH was 298 days (229–322). ROC analysis revealed strongest discrimination for mortality by hsTnT at 48 h after HTX [AUC = 0.79 95% CI 0.71–0.87]. According to Youden Index, the cutoff for hsTnT at 48 h and mortality was 1640 ng/l. After adjustment for IMPACT score multivariate logistic and linear regression showed independent associations between hsTnT and mortality/DAOH with odds ratio of 8.10 [95%CI 2.99–21.89] and unstandardized regression coefficient of −1.54 [95%CI −2.02 to −1.06], respectively. CONCLUSION: Postoperative hsTnT might be suitable as an early prognostic marker after HTX and is independently associated with 1-year mortality and poor DAOH. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40001-022-00978-4. BioMed Central 2023-01-09 /pmc/articles/PMC9827673/ /pubmed/36624515 http://dx.doi.org/10.1186/s40001-022-00978-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research M’Pembele, René Roth, Sebastian Nucaro, Anthony Stroda, Alexandra Tenge, Theresa Lurati Buse, Giovanna Bönner, Florian Scheiber, Daniel Ballázs, Christina Tudorache, Igor Aubin, Hug Lichtenberg, Artur Huhn, Ragnar Boeken, Udo Postoperative high-sensitivity troponin T predicts 1-year mortality and days alive and out of hospital after orthotopic heart transplantation |
title | Postoperative high-sensitivity troponin T predicts 1-year mortality and days alive and out of hospital after orthotopic heart transplantation |
title_full | Postoperative high-sensitivity troponin T predicts 1-year mortality and days alive and out of hospital after orthotopic heart transplantation |
title_fullStr | Postoperative high-sensitivity troponin T predicts 1-year mortality and days alive and out of hospital after orthotopic heart transplantation |
title_full_unstemmed | Postoperative high-sensitivity troponin T predicts 1-year mortality and days alive and out of hospital after orthotopic heart transplantation |
title_short | Postoperative high-sensitivity troponin T predicts 1-year mortality and days alive and out of hospital after orthotopic heart transplantation |
title_sort | postoperative high-sensitivity troponin t predicts 1-year mortality and days alive and out of hospital after orthotopic heart transplantation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827673/ https://www.ncbi.nlm.nih.gov/pubmed/36624515 http://dx.doi.org/10.1186/s40001-022-00978-4 |
work_keys_str_mv | AT mpembelerene postoperativehighsensitivitytroponintpredicts1yearmortalityanddaysaliveandoutofhospitalafterorthotopichearttransplantation AT rothsebastian postoperativehighsensitivitytroponintpredicts1yearmortalityanddaysaliveandoutofhospitalafterorthotopichearttransplantation AT nucaroanthony postoperativehighsensitivitytroponintpredicts1yearmortalityanddaysaliveandoutofhospitalafterorthotopichearttransplantation AT strodaalexandra postoperativehighsensitivitytroponintpredicts1yearmortalityanddaysaliveandoutofhospitalafterorthotopichearttransplantation AT tengetheresa postoperativehighsensitivitytroponintpredicts1yearmortalityanddaysaliveandoutofhospitalafterorthotopichearttransplantation AT luratibusegiovanna postoperativehighsensitivitytroponintpredicts1yearmortalityanddaysaliveandoutofhospitalafterorthotopichearttransplantation AT bonnerflorian postoperativehighsensitivitytroponintpredicts1yearmortalityanddaysaliveandoutofhospitalafterorthotopichearttransplantation AT scheiberdaniel postoperativehighsensitivitytroponintpredicts1yearmortalityanddaysaliveandoutofhospitalafterorthotopichearttransplantation AT ballazschristina postoperativehighsensitivitytroponintpredicts1yearmortalityanddaysaliveandoutofhospitalafterorthotopichearttransplantation AT tudoracheigor postoperativehighsensitivitytroponintpredicts1yearmortalityanddaysaliveandoutofhospitalafterorthotopichearttransplantation AT aubinhug postoperativehighsensitivitytroponintpredicts1yearmortalityanddaysaliveandoutofhospitalafterorthotopichearttransplantation AT lichtenbergartur postoperativehighsensitivitytroponintpredicts1yearmortalityanddaysaliveandoutofhospitalafterorthotopichearttransplantation AT huhnragnar postoperativehighsensitivitytroponintpredicts1yearmortalityanddaysaliveandoutofhospitalafterorthotopichearttransplantation AT boekenudo postoperativehighsensitivitytroponintpredicts1yearmortalityanddaysaliveandoutofhospitalafterorthotopichearttransplantation |